242 related articles for article (PubMed ID: 27929743)
1. Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey.
Beck M; Michel B; Rybarczyk-Vigouret MC; Levêque D; Sordet C; Sibilia J; Velten M
MAbs; 2017; 9(2):383-390. PubMed ID: 27929743
[TBL] [Abstract][Full Text] [Related]
2. Rheumatologists' Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey.
Beck M; Michel B; Rybarczyk-Vigouret MC; Levêque D; Sordet C; Sibilia J; Velten M;
BioDrugs; 2016 Dec; 30(6):585-592. PubMed ID: 27848166
[TBL] [Abstract][Full Text] [Related]
3. Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals.
Pawłowska I; Pawłowski L; Krzyżaniak N; Kocić I
BioDrugs; 2019 Apr; 33(2):183-191. PubMed ID: 30830647
[TBL] [Abstract][Full Text] [Related]
4. Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland.
O'Callaghan J; Bermingham M; Leonard M; Hallinan F; Morris JM; Moore U; Griffin BT
Regul Toxicol Pharmacol; 2017 Aug; 88():252-261. PubMed ID: 28666961
[TBL] [Abstract][Full Text] [Related]
5. Awareness and Knowledge of Pharmacists toward Biosimilar Medicines: A Survey in Jordan.
Oqal M; Hijazi B; Alqudah A; Al-Smadi A; A Almomani B; Alnajjar R; Abu Ghunaim M; Irshaid M; Husam A
Int J Clin Pract; 2022; 2022():8080308. PubMed ID: 35832802
[TBL] [Abstract][Full Text] [Related]
6. A survey of pharmacists' knowledge and views of biosimilars in Quebec and France.
Adé A; Bourdon O; Bussières JF
Ann Pharm Fr; 2017 Jul; 75(4):267-275. PubMed ID: 28237527
[TBL] [Abstract][Full Text] [Related]
7. Malaysian Hospital Pharmacists' Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey.
Mohd Sani N; Aziz Z; Kamarulzaman A
BioDrugs; 2023 Jan; 37(1):109-120. PubMed ID: 36571697
[TBL] [Abstract][Full Text] [Related]
8. Patients' information and perspectives on biosimilars in rheumatology: A French nation-wide survey.
Frantzen L; Cohen JD; Tropé S; Beck M; Munos A; Sittler MA; Diebolt R; Metzler I; Sordet C
Joint Bone Spine; 2019 Jul; 86(4):491-496. PubMed ID: 30659920
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist biosimilar survey reveals knowledge gaps.
Stevenson JG; McCabe D; McGrath M; McBride A
J Am Pharm Assoc (2003); 2023; 63(2):529-537.e7. PubMed ID: 36437154
[TBL] [Abstract][Full Text] [Related]
10. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians.
Barbier L; Vandenplas Y; Simoens S; Declerck P; Vulto AG; Huys I
J Pharm Policy Pract; 2021 Jun; 14(1):53. PubMed ID: 34158128
[TBL] [Abstract][Full Text] [Related]
11. Differences in UK healthcare professionals' knowledge, attitude and practice towards infliximab and insulin glargine biosimilars.
Aladul MI; Fitzpatrick RW; Chapman SR
Int J Pharm Pract; 2019 Apr; 27(2):214-217. PubMed ID: 30160324
[TBL] [Abstract][Full Text] [Related]
12. [Knowledge and perceptions of biosimilar medicines by health professionals in Tunisia].
Mhiri A; Khemakhem M; Kalboussi N; Kacem B
Ann Pharm Fr; 2022 May; 80(3):327-339. PubMed ID: 34428456
[TBL] [Abstract][Full Text] [Related]
13. Healthcare professionals' perceptions and perspectives on biosimilar medicines and the barriers and facilitators to their prescribing in UK: a qualitative study.
Aladul MI; Fitzpatrick RW; Chapman SR
BMJ Open; 2018 Nov; 8(11):e023603. PubMed ID: 30455389
[TBL] [Abstract][Full Text] [Related]
14. A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners.
Foreman E; Patel H; Siderov J; Harchowal J; Bubalo J; Chan A
J Oncol Pharm Pract; 2020 Apr; 26(3_suppl):22-32. PubMed ID: 32268828
[TBL] [Abstract][Full Text] [Related]
15. Knowledge, attitudes, and practices of pharmacists toward biosimilar medicines in Nigeria.
Okoro RN; Hedima EW; Aguiyi-Ikeanyi CN
J Am Pharm Assoc (2003); 2022; 62(1):79-85.e2. PubMed ID: 34654651
[TBL] [Abstract][Full Text] [Related]
16. Knowledge and attitudes of German and Swiss community pharmacists towards biologicals and biosimilars - a prospective survey before and after the COVID-19 pandemic.
Messner K; Eickhoff C; Schulz M; Allemann SS; Arnet I
BMC Health Serv Res; 2023 Dec; 23(1):1432. PubMed ID: 38110932
[TBL] [Abstract][Full Text] [Related]
17. European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical Practice.
Barbier L; Simoens S; Vulto AG; Huys I
BioDrugs; 2020 Dec; 34(6):797-808. PubMed ID: 33063267
[TBL] [Abstract][Full Text] [Related]
18. Pharmacists' Perspectives of Biosimilars: A Systematic Review.
Mohd Sani N; Aziz Z; Panickar R; Kamarulzaman A
BioDrugs; 2022 Jul; 36(4):489-508. PubMed ID: 35776294
[TBL] [Abstract][Full Text] [Related]
19. Patients' Understanding and Attitudes Towards Infliximab and Etanercept Biosimilars: Result of a UK Web-Based Survey.
Aladul MI; Fitzpatrick RW; Chapman SR
BioDrugs; 2017 Oct; 31(5):439-446. PubMed ID: 28752242
[TBL] [Abstract][Full Text] [Related]
20. Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: A national survey.
Marín-Jiménez I; Carrascosa JM; Guigini MA; Monte-Boquet E
Farm Hosp; 2021 Jul; 45(5):240-246. PubMed ID: 34806583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
